Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin.
Sigal AC, Keenan M, Lazova R.
Am J Dermatopathol. 2012 Apr;34(2):145-50.
Related citations
Imaging mass spectrometry--a new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas.
Lazova R, Seeley EH, Keenan M, Gueorguieva R, Caprioli RM.
Am J Dermatopathol. 2012 Feb;34(1):82-90.
pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas.
Schimming TT, Grabellus F, Roner M, Pechlivanis S, Sucker A, Bielefeld N, Moll I, Schadendorf D, Hillen U.
Am J Dermatopathol. 2012 May;34(3):266-9.
Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.
Hoshimoto S, Faries MB, Morton DL, Shingai T, Kuo C, Wang HJ, Elashoff R, Mozzillo N, Kelley MC, Thompson JF, Lee JE, Hoon DS.
Ann Surg. 2012 Feb;255(2):357-62.
Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer.
Brouwer OR, Klop WM, Buckle T, Vermeeren L, van den Brekel MW, Balm AJ, Nieweg OE, Valdés Olmos RA, van Leeuwen FW.
Ann Surg Oncol. 2012 Jun;19(6):1988-94. Epub 2011 Dec 30.
Retrospective study of patients with brain metastases from melanoma receiving concurrent whole-brain radiation and temozolomide.
Devito N, Yu M, Chen R, Pan E.
Anticancer Res. 2011 Dec;31(12):4537-43.
Characterization of T-cell memory phenotype after in vitro expansion of tumor-infiltrating lymphocytes from melanoma patients.
Zhou J, Nagarkatti P, Zhong Y, Nagarkatti M.
Anticancer Res. 2011 Dec;31(12):4099-109.
Assessing students' ability to detect melanomas using standardized patients and moulage.
Hernandez C, Mermelstein R, Robinson JK, Yudkowsky R.
J Am Acad Dermatol. 2011 Dec 22. [Epub ahead of print]
Surgical margins for melanoma in situ.
Kunishige JH, Brodland DG, Zitelli JA.
J Am Acad Dermatol. 2012 Mar;66(3):438-44. Epub 2011 Dec 22.
Skin carcinogenesis and driving.
Cameron H, Grannis FW Jr.
J Am Acad Dermatol. 2011 Dec;65(6):1228-9. No abstract available.
Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma.
Maur M, Tomasello C, Frassoldati A, Dieci MV, Barbieri E, Conte P.
J Clin Oncol. 2012 Feb 20;30(6):e76-8. Epub 2011 Dec 27. No abstract available.
Identification of an HLA-DPB1*0501 restricted Melan-A/MART-1 epitope recognized by CD4+ T lymphocytes: prevalence for immunotherapy in Asian populations.
Meng Z, Wang Y, Zhang G, Ke Y, Yan Y, Wu L, Huang Q, Zeng G, Wang Y, Ying H, Jiao S.
J Immunother. 2011 Sep;34(7):525-34.
Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.
Liu H, Wei Q, Gershenwald JE, Prieto VG, Lee JE, Duvic M, Grimm EA, Wang LE.
Melanoma Res. 2012 Apr;22(2):169-75.
Targeting protein-trafficking pathways alters melanoma treatment sensitivity.
Huang ZM, Chinen M, Chang PJ, Xie T, Zhong L, Demetriou S, Patel MP, Scherzer R, Sviderskaya EV, Bennett DC, Millhauser GL, Oh DH, Cleaver JE, Wei ML.
Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):553-8. Epub 2011 Dec 27.
Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination.
Kratky W, Reis e Sousa C, Oxenius A, Spörri R.
Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17414-9. Epub 2011 Oct 10.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on